Delivery Order SPE2DB24D3015-SPE2DB25FFYWX
Award Date
4/10/25
Potential Completion Date
4/11/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Rexulti 0.5 mg tablets, a prescription medication. The delivery order has a ceiling value of $8,885.04 and a completion date of April 9, 2025. This contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,595.96, is for the delivery of the prescription medication Rexulti 0.5 mg tablet. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,545.19, is for the delivery of Rexulti 0.5 mg tablets. It is a firm fixed-price contract with an ultimate completion date of October 25, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This $10,959.63 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets. The order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. AmerisourceBergen, a major pharmaceutical distributor, is the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of the prescription medication Rexulti 3 mg tablets, with a total ceiling value of $11,651.00. The contract is firm-fixed price and has an ultimate completion date of August 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,470.83 firm fixed-price contract is for the supply of the prescription drug Rexulti 2 mg tablets, with a period of performance through April 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,268.37, is for the delivery of the prescription medication Rexulti 0.5 mg tablets. It is a firm fixed-price contract with an ultimate completion date of April 11, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $26,646.43 fixed-price contract is for the delivery of Rexulti 0.5 mg tablets, a medication used to treat certain mental health conditions. The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Rexulti 2 mg tablets. The contract has a ceiling value of $6,417.44 and a period of performance through November 24, 2023. It is a firm-fixed-price contract and was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, as the prime contractor. The contract is for the supply of 4,563,982,168 tablets of the pharmaceutical product Rexulti 1 mg. The delivery order has a firm fixed price of $2,656.00 and a completion date of March 18, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December...